Cargando…
Donor-derived cell-free DNA as a diagnostic tool in transplantation
There is a need to improve personalized immunosuppression in organ transplantation to reduce premature graft loss. Biomarkers are needed to better detect rejection, asymptomatic graft injury, and under-immunosuppression. Assessment of minimal necessary exposure to guide tapering and prevent immune a...
Autores principales: | Oellerich, Michael, Budde, Klemens, Osmanodja, Bilgin, Bornemann-Kolatzki, Kirsten, Beck, Julia, Schütz, Ekkehard, Walson, Philip D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9634115/ https://www.ncbi.nlm.nih.gov/pubmed/36339004 http://dx.doi.org/10.3389/fgene.2022.1031894 |
Ejemplares similares
-
Donor-Derived Cell-Free DNA for Kidney Allograft Surveillance after Conversion to Belatacept: Prospective Pilot Study
por: Osmanodja, Bilgin, et al.
Publicado: (2023) -
Donor-Derived Cell-Free DNA in Biopsy-Proven Antibody-Mediated Rejection Versus Recurrent IgA Nephropathy After Kidney Transplantation
por: Akifova, Aylin, et al.
Publicado: (2023) -
Absolute or Relative Quantification of Donor-derived Cell-free DNA in Kidney Transplant Recipients: Case Series
por: Osmanodja, Bilgin, et al.
Publicado: (2021) -
Genome Aberrations in Canine Mammary Carcinomas and Their Detection in Cell-Free Plasma DNA
por: Beck, Julia, et al.
Publicado: (2013) -
Absolute quantification of donor‐derived cell‐free DNA as a marker of rejection and graft injury in kidney transplantation: Results from a prospective observational study
por: Oellerich, Michael, et al.
Publicado: (2019)